July 2014 tender notification

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2013/14 Invitation to Tender, dated 07 November 2013.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.

Where a product does not have a current Pharmacode, suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2013/14 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2017

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

Amendment to June Tender notification (Sole Subsidised Supply date) in bold and strike through

Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy and (price) New subsidy and price Sole supply brand
(Supplier)
Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) Brand (Supplier) affected by reference pricing and delisting
Tar with triethanolamine lauryl sulphate and fluorescein Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium;
500 ml, bottle
$3.05 per 500 ml $3.36 per 500 ml Pinetarsol
(Douglas)
1 October 2014 n/a 1 March 2014 2015 Pinetarsol
(1,000 ml pack size)
(Douglas)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

Amendment to June Tender notification (pack size) in bold

Tenders awarded to listed pharmaceuticals where only the current brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current pack price New pack price Hospital Supply Brand (Supplier) DVLimit Date of price change Hospital Supply Status date
Morphine sulphate Inj 1 mg per ml, 10 ml syringe;
10 syringes
$39.50 $45.00 Biomed
(Biomed)
1% 1 August 2014 1 October 2014
Morphine sulphate Inj 1 mg per ml, 50 ml syringe;
10 syringes
$79.50 $87.50 Biomed
(Biomed)
1% 1 August 2014 1 October 2014
Morphine sulphate Inj 1 mg per ml, 100 ml bag;
10 bags
$165.00 $185.00 Biomed
(Biomed)
1% 1 August 2014 1 October 2014

2013/14 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2017

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current subsidy and (price) New subsidy and price Sole supply brand
(Supplier)
Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) Brand (Supplier) affected by reference pricing and delisting
Docusate sodium Tab 50 mg; 100 tablet, bottle $2.57 $2.31 Coloxyl
(Aspen Pharma)
1 November 2014 1 January 2015 1 April 2015 Laxofast 50
(Actavis)
Docusate sodium Tab 120 mg; 100 tablet, bottle $3.48 $3.13 Coloxyl
(Aspen Pharma)
1 November 2014 1 January 2015 1 April 2015 Laxofast 120
(Actavis)
Finasteride Tab 5 mg; 28 tablet, blister pack $5.10 per 30 tablets $1.95 Finpro
(Dr Reddy’s)
1 October 2014 1 December 2014 1 March 2015 Rex Medical
(Rex Medical)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current pack price New pack price Hospital Supply Brand (Supplier) DVLimit Date of listing/price change for tender winning brand Hospital Supply Status date (and delisting of other listed brands) Brand (Supplier) to be delisted
Docetaxel Inj 20 mg; 1 vial $48.75 $13.70 DBL Docetaxel
(Hospira)
1% 1 October 2014 1 December 2014 Docetaxel Sandoz

(Novartis)
Docetaxel Inj 80 mg; 1 vial $195.00 $29.99 DBL Docetaxel
(Hospira)
1% 1 October 2014 1 December 2014 Docetaxel Sandoz

(Novartis)
Docusate sodium Tab 50 mg; 100 tablet, bottle $2.57 $2.31 Coloxyl
(Aspen Pharma)
1% 1 November 2014 1 January 2015 Laxofast 50
(Actavis)
Docusate sodium Tab 120 mg; 100 tablet, bottle $3.48 $3.13 Coloxyl
(Aspen Pharma)
1% 1 November 2014 1 January 2015 Laxofast 120 (Actavis)
Finasteride Tab 5 mg; 28 tablet, blister pack $5.10 per 30 tablets $1.95 Finpro

(Dr Reddy’s)
1% 1 October 2014 1 December 2014 Rex Medical
(Rex Medical)
The price and subsidy of docetaxel (PCT – Retail Pharmacy Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 October 2014. The subsidy for docetaxel inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $2.63 per 1 mg to $0.61 per 1 mg from 1 October 2014.

Tenders awarded to pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Pack price Hospital Supply Brand (Supplier) DVLimit Listing date Hospital Supply Status date
Ticarcillin with clavulanic acid Inj ticarcillin 3 g with clavulanic acid 0.1 mg vial;
1 vial
$22.00 Timentin
(GSK)
1% 1 December 2014 1 February 2015

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2011/12 Invitation to Tender, dated 2 November 2011, the 2012/13 Invitation to Tender, dated 31 October 2012, and the 2013/14 Invitation to Tender, dated 07 November 2013:

2011/12 Invitation to Tender

Chemical name Line item
Bupivacaine hydrochloride Inj 0.5%, 10 ml
Oxycodone hydrochloride Cap 5 mg
Oxycodone hydrochloride Cap 10 mg
Oxycodone hydrochloride Cap 20 mg

2012/13 Invitation to Tender

Chemical name Line item

Beclomethasone Dipropionate

Metered aqueous nasal spray, 50 mcg per dose

Beclomethasone Dipropionate

Metered aqueous nasal spray, 100 mcg per dose

Betamethasone Valerate

Crm 0.1%

Betamethasone Valerate

Lotn 0.1%

Bisacodyl

Tab 5 mg

Budesonide

Metered aqueous nasal spray, 50 mcg per dose

Budesonide

Metered aqueous nasal spray, 100 mcg per dose

Cetomacrogol

Crm BP

Cholecalciferol

Tab 1.25 mg (50,000 iu)

Ciprofloxacin

Inj  2 mg/ml, 100 ml

Co-Trimoxazole

Tab trimethoprim 80 mg and sulphamethoxazole 400 mg

Docusate Sodium with Sennosides

Tab 50 mg with total sennosides 8 mg

Hydrocortisone with Miconazole

Crm 1% with miconazole nitrate 2%

Lorazepam

Inj 4 mg per ml, 1 ml

Lorazepam

Tab 1 mg

Lorazepam

Tab 2.5 mg

Magnesium

Tab

Methadone hydrochloride

Tab 5 mg

Mupirocin

Oint 2%

Nystatin

Cap 500,000 u

Nystatin

Tab 500,000 u

Pegylated liposomal doxorubicin

Inj 20 mg

Pegylated liposomal doxorubicin

Inj 50 mg

Prednisolone

Oral liq 5 mg per ml

Solifenacin succinate

Tab 10mg

Solifenacin succinate

Tab 5mg

Thalidomide

Cap 50 mg

Thalidomide

Cap 100 mg

Valaciclovir

Tab 250 mg

Valaciclovir

Tab 500 mg

Valaciclovir

Tab 1000 mg

2013/14 Invitation to Tender

Chemical name Line item
Nitrofurantoin Tab 50 mg
Nitrofurantoin Tab 100 mg
Tramadol hydrochloride Oral drops 100 mg per ml
Tramadol hydrochloride Tab sustained release 50 mg

PHARMAC has resolved not to award tenders for Hospital Supply Status for the following products listed in the 2013/14 Invitation to Tender, dated 07 November 2013:

Chemical name Line item
Tar with triethanolamine lauryl sulphate and fluorescein Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium

For products included in the 2012/13 or the 2013/14 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made. 

If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.